Since the 1950s, some have divided antimicrobial resistance into two forms: hospital acquired and community acquired. This division is useful both mechanistically and epidemiologically and can be applied to gram-negative bacilli.
Gram-negative bacilli produce either chromosomal or plasmid-mediated 9-lactamases. That is the major clinically important difference between the 13-lactamases in terms of treating patients. The chromosomal-mediated ~-lactamases are found primarily in hospital-associated organisms in the intensive care unit; they have developed the ability to inactivate the latest cephalosporins. Plasmidmediated [3-1actamases are most common in commtmity-associated organisms, which, until now, have been susceptible to third-generation cephalosporins.
Chromosomally mediated resistance is not passed horizontally from organism to organism, but rather is passed only vertically. Thus, an infecting organism must multiply to 10 or 100 million in order to yield 100 or 1,000 resistant mutants.
Reasonable cleanliness in intensive care units should enable control of resistance due to this mechanism.
Among community-acquired gram-negative bacilli, resistance genes are carried primarily on plasmid, rather than chromosomal, DNA. Plasmid DNA may be passed horizontally between infecting organisms. Recently, plasmid-mediated resistance to the latest generation of cephalosporins has occurred in hospitalassociated gram-negative bacilli. The inactivation of a late-generation cephalosporin by that plasmid-mediated [3-1actamase threatens to leap from hospitalacquired organisms into the community. An example of this can be seen in a Salmonella species in Spain that is resistant to third-generation cephalosporins. 1
The ominous implication is that if a plasmid-mediated [3-1actamase that can inactivate late-generation cephalosporins spreads to these type of organisms, we will be in much more trouble. Many believe that this is predictable.
Evidence is increasing that a combination of ~-lactamase activity and decreased 
